First 'perovskite camera' can see inside the human body

Whether training for a marathon, fitting in a quick gym session after work, or running onto the footy field for a professional match, it seems that the warm-up might be just as important as the exercise itself.

Giving birth is hard enough; postpartum depression can make adjusting to parenthood all the more difficult. A healthy diet is essential for new mothers to build strength after such a taxing ordeal, but what if what they eat could also lower the risk of baby blues?

Researchers from the University of Adelaide have taken existing questionnaires used to measure chronic pain and made them accessible for children and young people with cerebral palsy.

University of Oxford-led research finds low-dose rapamycin functions as a genomic protector in aging human immune cells, lowering DNA damage.

An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes—known as extrachromosomal DNA, or ecDNA—can drive the growth of a large proportion of glioblastomas, the most common and aggressive adult brain cancer. The discovery could open the door to much-needed new approaches to diagnose glioblastoma early, track its progress and treat it more effectively.

Researchers at the University of Alberta have found a way to measure how engaged people living with dementia are when they're playing a computer game—which could pave the way to new treatments that use gaming to stave off the onset or progression of cognitive decline.

Researchers have uncovered new evidence that challenges long-standing beliefs about asymptomatic malaria infections. The study, led by Monash University's Professor Diana Hansen and published in Molecular Systems Biology, focused on Plasmodium vivax, the most widespread malaria parasite and a major obstacle to global elimination efforts.

An international group of researchers has developed a new tool that can help identify problematic randomized controlled trials (RCTs), including fraudulent studies, where there are serious concerns about trustworthiness.

It was March 2020, and Robert Gordon was about to kick some 80,000 people off health insurance.

Creatine is shedding its gym-bro reputation, unlocking lucrative new markets as women and older Americans get wise to the benefits of the long-stigmatized supplement. Sales are booming as a result.

Seniors in some parts of the country say they are being denied COVID-19 vaccinations amid an ongoing spike in cases, leading to rising frustration over new Trump administration policies that are making it harder to get the shots.

A cup of coffee or tea in the morning or an afternoon caffeine pick-me-up is usually fine for most adults. But parents might want to take a closer look at caffeine and other ingredients in the drinks their kids love.

For doctors and patients, the Holy Grail of medicine would be a simple blood or saliva test to detect all types of cancer before symptoms or sickness appears. Doctors could screen and treat patients earlier in the course of disease. As Dr. Lisa Stempel, director of the high-risk cancer screening program at Rush University Medical Center, told the Tribune recently, "The goal of all screening is to find cancer early when we can treat it."

The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States.

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April.

Using alcohol, tobacco, marijuana or other substances during pregnancy can harm the developing fetus, even when the risks are not always obvious, a West Virginia University psychiatrist warns.

Amy Frank said it took 17 hours on the phone over nearly three weeks, bouncing between her insurer and her local hospital system, to make sure her plan would cover her husband's post-surgery care.

Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest that adjuvant chemo-immunotherapy may reduce the risk of recurrence in patients with completely resected stage IB–IIIA non-small cell lung cancer (NSCLC) while maintaining an acceptable safety profile.